Substance / Medication

Doxapram

Overview

Active Ingredient
doxapram
RxNorm CUI
3637

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

5 trials linked to this intervention

5
Total Trials
2
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Doxapram for the prevention and treatment of apnea in preterm infants.
Evans Shannon, Avdic Ema, Pessano Sara et al. · Cochrane Database Syst Rev · 2023
PMID: 37877431Meta-AnalysisFull text (PMC)
Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
Vliegenthart Roseanne J S, Ten Hove Christine H, Onland Wes et al. · Neonatology · 2017
PMID: 27760427Meta-AnalysisFull text (PMC)
Doxapram treatment for apnea in preterm infants.
Henderson-Smart D, Steer P · Cochrane Database Syst Rev · 2004
PMID: 15494987Meta-AnalysisFull text (PMC)
Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.
Greenstone M, Lasserson T J · Cochrane Database Syst Rev · 2003
PMID: 12535393Meta-Analysis
Doxapram treatment for apnea in preterm infants.
Henderson-Smart D J, Steer P A · Cochrane Database Syst Rev · 2001
PMID: 11687067Meta-Analysis
Doxapram treatment for apnea in preterm infants.
Henderson-Smart D J, Steer P A · Cochrane Database Syst Rev · 2000
PMID: 10796114Meta-Analysis
Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.
Greenstone M · Cochrane Database Syst Rev · 2000
PMID: 10796514Meta-Analysis
Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation.
Henderson-Smart D J, Davis P G · Cochrane Database Syst Rev · 2000
PMID: 10908519Meta-AnalysisFull text (PMC)
Doxapram versus methylxanthine for apnea in preterm infants.
Henderson-Smart D J, Steer P · Cochrane Database Syst Rev · 2000
PMID: 11034672Meta-Analysis
Doxapram versus methylxanthine for apnea in preterm infants.
Henderson-Smart D J, Steer P · Cochrane Database Syst Rev · 2000
PMID: 10796115Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Doxapram (substance)
SNOMED CT
373339005
UMLS CUI
C0013084
RxNorm CUI
3637

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
5
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.